ClinicalTrials.Veeva

Menu

Effectiveness Fluoride Varnishes in Children With Early Childhood Caries

M

Merve Erkmen Almaz

Status

Completed

Conditions

Early Childhood Caries

Treatments

Drug: Sodium Fluoride with TCP
Drug: Sodium Fluoride with CXP
Drug: Sodium Fluoride
Drug: Sodium Fluoride with CPP-ACP

Study type

Interventional

Funder types

Other

Identifiers

NCT03625310
Kirikkale University

Details and patient eligibility

About

The study was carried out in 88 children with severe early childhood caries (dmfs≥age +1) who were referred to the investigators' clinic. Patients who completed dental treatment under general anesthesia in a single session, were included to the study.

Patients were divided randomly into 4 groups and after dental treatment one of the fluoride varnish listed below was applied to each child. The groups were as follows;

  1. Duraphat varnish containing 5% Sodium Fluoride (Colgate) (n = 22),
  2. Clinpro ™ White Varnish containing 5% of Sodium Fluoride tricalcium phosphate (3M ESPE) (n = 22),
  3. Embrace ™ Varnish containing 5% Sodium Fluoride with CXP ™ (Pulpdent) (n = 22),
  4. MI Varnish containing 5% Sodium Fluoride casein phosphopeptide amorphous calcium phosphate varnish (GC) (n = 22).

Saliva Mutans streptococci (MS) and Lactobacilli (LB) levels, were evaluated by taking saliva samples before general anaesthesia; one month after treatment and three months after treatment.

Full description

Duraphat (Colgate), which we used as a positive control group in our study, contains only 5% sodium fluoride. It has been reported in studies that Duraphat is effective in remineralization.

Clinpro ™ White Varnish, another topical varnish in this study,was reported to be effective for caries prevention in pre-school children.

One of the varnishes we evaluate in the study, Embrace™ Varnish, contains 5% sodium fluoride with xylitol-coated calcium and phosphate. According to the manufacturer, the xylitol coating prevents the calcium and phosphate salts from reacting until they come in contact with saliva. Saliva dissolves the xylitol and releases the calcium and phosphate ions, which react with the fluoride ions in saliva to form protective fluorapatite on the teeth19 MI Varnish, in the fourth group containing 5% sodium fluoride with casein phosphopeptide amorphous calcium phosphate (CPP-ACP) had a high release of calcium and fluoride ions.

Enrollment

88 patients

Sex

All

Ages

36 to 72 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of healthy children with severe early childhood caries,
  • younger than 6 years in the primary dentition

Exclusion criteria

  • history of any chronic disease,
  • use of any drugs that reduce salivary flow or antibiotics in the last 4 weeks,
  • use of systemic fluoride tablets

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

88 participants in 4 patient groups

Sodium Fluoride
Active Comparator group
Description:
Varnish containing 5% Sodium Fluoride, was applied to all remaining teeth of each child after dental treatment under general anaesthesia.
Treatment:
Drug: Sodium Fluoride
Sodium Fluoride with TCP
Experimental group
Description:
Varnish containing 5% Sodium Fluoride with tricalcium phosphate (TCP) ,varnish was applied to all remaining teeth of each child after dental treatment under general anaesthesia.
Treatment:
Drug: Sodium Fluoride with TCP
Sodium Fluoride with CXP
Experimental group
Description:
Varnish containing 5% Sodium Fluoride with Xylitol-coated Calcium and Phosphate (CXP) ,varnish was applied to all remaining teeth of each child after dental treatment under general anaesthesia.
Treatment:
Drug: Sodium Fluoride with CXP
Sodium Fluoride with CPP-ACP
Experimental group
Description:
Varnish containing 5% Sodium Fluoride with casein phosphopeptide amorphous calcium phosphate (CPP-ACP), varnish was applied to all remaining teeth of each child after dental treatment under general anaesthesia.
Treatment:
Drug: Sodium Fluoride with CPP-ACP

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems